22.00 USD
▲-0.43+1.01%
盘后 21.80 +0.09%
2026-08-03
市值
$255.43M
市盈率
—
EPS
-36.80
股息率
—
52 周区间
9.03 – 35.00
成交量
274.85K
Beta
0.51
目标价
42.50
52W 低 9.0352W 高 35.00
价格走势
公司简介
Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzled 4 (Fzd4 agonism) and vascular endothelial growth factor (VEGF antagonism) to treat diabetic macular edema (DME), neovascular ag...